The MyBody-X angle on gluten in children centers on DNA-based risk assessment for celiac disease (HLA-DQ2/DQ8 variants). However, a genetic predisposition does not equal disease – many carriers remain asymptomatic. For non-celiac gluten sensitivity, no reliable genetic markers exist; diagnosis relies on symptom tracking and medical exclusion. Consumer tests often overstate the predictive power. In children, never start a gluten-free diet without professional guidance, as it may mask other conditions or cause nutritional deficiencies. Evidence is mixed: strong for celiac genetics, weak for broader gluten sensitivity. MyBody-X markets these tests as lifestyle insights, not medical tools. Caveat: results require pediatric interpretation and should not replace clinical evaluation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-8ca9410f4daf7a130ddc8515